CR8530A - Intermediarios de quinolona como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos - Google Patents
Intermediarios de quinolona como inhibidores de receptores de tirosina quinasas y la sintesis de los mismosInfo
- Publication number
- CR8530A CR8530A CR8530A CR8530A CR8530A CR 8530 A CR8530 A CR 8530A CR 8530 A CR8530 A CR 8530A CR 8530 A CR8530 A CR 8530A CR 8530 A CR8530 A CR 8530A
- Authority
- CR
- Costa Rica
- Prior art keywords
- inhibitors
- quinolona
- intermediaries
- synthesis
- same
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- -1 4-substituted quinoline compounds Chemical class 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229940127361 Receptor Tyrosine Kinase Inhibitors Drugs 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Metodos de preparacion de compuestos de quinolina 4-sustituida como intermediarios en la elaboracion de inhibidores de tirosina quinasas de receptores y los compuestos intermediarios utilizados en dichos metodos, donde dicho compuesto quinolina 4-sustituida presenta la siguiente formula general (I): y donde las sustituciones en LG", PG, A, G, R1 y R4 son las que se describieron en la memoria descriptiva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53732904P | 2004-01-16 | 2004-01-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8530A true CR8530A (es) | 2008-09-23 |
Family
ID=34807094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8530A CR8530A (es) | 2004-01-16 | 2006-07-24 | Intermediarios de quinolona como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos |
Country Status (20)
Country | Link |
---|---|
US (2) | US7432377B2 (es) |
EP (1) | EP1711467A2 (es) |
KR (1) | KR20060123545A (es) |
CN (1) | CN1930128A (es) |
AR (1) | AR047424A1 (es) |
AU (1) | AU2005206541A1 (es) |
BR (1) | BRPI0520812A2 (es) |
CA (1) | CA2553729A1 (es) |
CR (1) | CR8530A (es) |
EC (1) | ECSP066773A (es) |
GT (1) | GT200500008A (es) |
MY (1) | MY136959A (es) |
NO (1) | NO20063501L (es) |
PA (1) | PA8621501A1 (es) |
PE (1) | PE20050896A1 (es) |
RU (1) | RU2006127414A (es) |
SG (1) | SG149817A1 (es) |
TW (1) | TW200526219A (es) |
UA (1) | UA85698C2 (es) |
WO (1) | WO2005070890A2 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT200500008A (es) | 2004-01-16 | 2005-08-16 | Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos | |
WO2006127203A2 (en) * | 2005-05-25 | 2006-11-30 | Wyeth | Methods of synthesizing 6-alkylaminoquinoline derivatives |
KR20080016671A (ko) * | 2005-05-25 | 2008-02-21 | 와이어쓰 | 치환된 3-시아노퀴놀린 및 그것의 중간체를 합성하는 방법 |
RU2007139544A (ru) * | 2005-05-25 | 2009-06-27 | Вайет (Us) | Способ получения 3-цианохинолинов и промежуточные соединения, полученные согласно данному способу |
TW200808728A (en) * | 2006-05-23 | 2008-02-16 | Wyeth Corp | Method of preparing 4-halogenated quinoline intermediates |
US8093246B2 (en) * | 2006-12-14 | 2012-01-10 | Lexicon Pharmaceuticals, Inc. | O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer |
PE20090717A1 (es) | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
US8063220B2 (en) | 2007-06-22 | 2011-11-22 | Richter Gedeon Nyrt. | Sulfonyl-quinoline derivatives |
ES2645689T3 (es) | 2008-05-21 | 2017-12-07 | Ariad Pharmaceuticals, Inc. | Derivados de fósforo como inhibidores de quinasas |
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
NZ589843A (en) | 2008-06-27 | 2012-12-21 | Avila Therapeutics Inc | Pyrimidine heteroaryl compounds and uses thereof as protein kinase inhibitors |
US11351168B1 (en) | 2008-06-27 | 2022-06-07 | Celgene Car Llc | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
JP5590040B2 (ja) | 2008-11-12 | 2014-09-17 | アリアド・ファーマシューティカルズ・インコーポレイテッド | キナーゼ阻害剤としてのピラジノピラジンおよび誘導体 |
DK2603081T3 (en) | 2010-08-10 | 2017-01-16 | Celgene Avilomics Res Inc | COLLECTED BY A BTK INHIBITOR |
TWI545115B (zh) | 2010-11-01 | 2016-08-11 | 阿維拉製藥公司 | 雜環化合物及其用途 |
JP5956999B2 (ja) | 2010-11-01 | 2016-07-27 | セルジーン アヴィロミクス リサーチ, インコーポレイテッド | ヘテロアリール化合物およびその使用 |
US8796255B2 (en) | 2010-11-10 | 2014-08-05 | Celgene Avilomics Research, Inc | Mutant-selective EGFR inhibitors and uses thereof |
EA201391626A1 (ru) | 2011-05-04 | 2014-03-31 | Ариад Фармасьютикалз, Инк. | Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака |
EP2770830A4 (en) | 2011-10-28 | 2015-05-27 | Celgene Avilomics Res Inc | METHODS OF TREATING A DISEASE OR DISEASE ASSOCIATED WITH TYROSINE KINASE BTK (BRUTON'S TYROSINE KINASE) |
ES2698298T3 (es) | 2012-03-15 | 2019-02-04 | Celgene Car Llc | Sales de un inhibidor de quinasa receptor de factor de crecimiento epidérmico |
EP2825041B1 (en) | 2012-03-15 | 2021-04-21 | Celgene CAR LLC | Solid forms of an epidermal growth factor receptor kinase inhibitor |
AU2013204563B2 (en) | 2012-05-05 | 2016-05-19 | Takeda Pharmaceutical Company Limited | Compounds for inhibiting cell proliferation in EGFR-driven cancers |
EP2935226A4 (en) | 2012-12-21 | 2016-11-02 | Celgene Avilomics Res Inc | HETEROARYL COMPOUNDS AND USES THEREOF |
CA2900012A1 (en) | 2013-02-08 | 2014-08-14 | Celgene Avilomics Research, Inc. | Erk inhibitors and uses thereof |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
US9415049B2 (en) | 2013-12-20 | 2016-08-16 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
EP3179858B1 (en) | 2014-08-13 | 2019-05-15 | Celgene Car Llc | Forms and compositions of an erk inhibitor |
MX2017002610A (es) | 2014-08-29 | 2017-10-11 | Tes Pharma S R L | INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA. |
WO2016034202A1 (en) * | 2014-09-01 | 2016-03-10 | Electrolux Appliances Aktiebolag | Support assembly |
AU2016333987A1 (en) | 2015-10-05 | 2018-05-10 | Ny State Psychiatric Institute | Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies |
CN105503720B (zh) * | 2015-12-31 | 2018-07-03 | 重庆威鹏药业有限公司 | 来那替尼中间体的制备方法 |
CN107501175A (zh) * | 2017-07-25 | 2017-12-22 | 广州大学 | 一种喹啉衍生物的合成方法 |
CN107417612A (zh) * | 2017-07-25 | 2017-12-01 | 广州大学 | 一种喹啉衍生物的合成方法 |
CN107501174A (zh) * | 2017-07-25 | 2017-12-22 | 广州大学 | 一种喹啉衍生物的合成方法 |
KR20210003160A (ko) | 2018-04-18 | 2021-01-11 | 콘스텔레이션 파마슈티칼스, 인크. | 메틸 변형 효소 조절제, 이의 조성물 및 용도 |
CN112262143A (zh) | 2018-05-21 | 2021-01-22 | 星座制药公司 | 甲基修饰酶的调节剂、其组合物和用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73073C2 (uk) | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
US6245760B1 (en) | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
JP2002500675A (ja) | 1997-05-28 | 2002-01-08 | アヴェンティス ファーマシューティカルズ プロダクツ インコーポレイテッド | 血小板由来成長因子及び/又はp56▲上lck▼チロシンキナーゼを阻害するキノリン及びキノキサリン化合物 |
EA004427B1 (ru) | 1998-09-29 | 2004-04-29 | Уайт Холдингз Корпорейшн | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ |
US6297258B1 (en) | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
GB9910577D0 (en) * | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
EP1294709A2 (en) | 2000-01-28 | 2003-03-26 | AstraZeneca AB | Quinoline derivatives and their use as aurora 2 kinase inhibitors |
EP1337513A1 (en) | 2000-11-02 | 2003-08-27 | AstraZeneca AB | 4-substituted quinolines as antitumor agents |
UA77200C2 (en) | 2001-08-07 | 2006-11-15 | Wyeth Corp | Antineoplastic combination of cci-779 and bkb-569 |
WO2003093240A1 (en) * | 2002-04-30 | 2003-11-13 | Yungjin Pharmaceutical Co., Ltd. | Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
CL2004000016A1 (es) | 2003-01-21 | 2005-04-15 | Wyeth Corp | Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina. |
US7365203B2 (en) * | 2003-09-15 | 2008-04-29 | Wyeth | Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile |
GT200500008A (es) | 2004-01-16 | 2005-08-16 | Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos | |
GB0509224D0 (en) | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Inhibitors of intracellular enzymatic activity |
-
2005
- 2005-01-14 GT GT200500008A patent/GT200500008A/es unknown
- 2005-01-14 TW TW094101148A patent/TW200526219A/zh unknown
- 2005-01-14 CN CNA2005800077483A patent/CN1930128A/zh active Pending
- 2005-01-14 BR BRPI0520812-2A patent/BRPI0520812A2/pt not_active IP Right Cessation
- 2005-01-14 US US11/036,408 patent/US7432377B2/en not_active Expired - Fee Related
- 2005-01-14 AU AU2005206541A patent/AU2005206541A1/en not_active Withdrawn
- 2005-01-14 SG SG200900078-7A patent/SG149817A1/en unknown
- 2005-01-14 PA PA20058621501A patent/PA8621501A1/es unknown
- 2005-01-14 KR KR1020067016319A patent/KR20060123545A/ko not_active Application Discontinuation
- 2005-01-14 RU RU2006127414/04A patent/RU2006127414A/ru not_active Application Discontinuation
- 2005-01-14 WO PCT/US2005/001384 patent/WO2005070890A2/en active Application Filing
- 2005-01-14 UA UAA200609099A patent/UA85698C2/ru unknown
- 2005-01-14 CA CA002553729A patent/CA2553729A1/en not_active Abandoned
- 2005-01-14 EP EP05711511A patent/EP1711467A2/en not_active Withdrawn
- 2005-01-15 MY MYPI20050166A patent/MY136959A/en unknown
- 2005-01-17 AR ARP050100169A patent/AR047424A1/es unknown
- 2005-01-17 PE PE2005000069A patent/PE20050896A1/es not_active Application Discontinuation
-
2006
- 2006-07-24 CR CR8530A patent/CR8530A/es not_active Application Discontinuation
- 2006-08-01 NO NO20063501A patent/NO20063501L/no not_active Application Discontinuation
- 2006-08-16 EC EC2006006773A patent/ECSP066773A/es unknown
-
2008
- 2008-08-28 US US12/200,120 patent/US20090030197A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005070890A2 (en) | 2005-08-04 |
SG149817A1 (en) | 2009-02-27 |
KR20060123545A (ko) | 2006-12-01 |
GT200500008A (es) | 2005-08-16 |
US20090030197A1 (en) | 2009-01-29 |
UA85698C2 (ru) | 2009-02-25 |
WO2005070890A3 (en) | 2005-11-03 |
RU2006127414A (ru) | 2008-02-27 |
PE20050896A1 (es) | 2005-11-14 |
MY136959A (en) | 2008-12-31 |
ECSP066773A (es) | 2006-11-16 |
AR047424A1 (es) | 2006-01-18 |
US20050159446A1 (en) | 2005-07-21 |
CN1930128A (zh) | 2007-03-14 |
PA8621501A1 (es) | 2005-08-10 |
CA2553729A1 (en) | 2005-08-04 |
AU2005206541A1 (en) | 2005-08-04 |
NO20063501L (no) | 2006-09-28 |
TW200526219A (en) | 2005-08-16 |
BRPI0520812A2 (pt) | 2009-10-06 |
EP1711467A2 (en) | 2006-10-18 |
US7432377B2 (en) | 2008-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR8530A (es) | Intermediarios de quinolona como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
AR047917A1 (es) | Derivados de 4-benzimidazol-2-il-piridazin-3-ona, preparacion de los mismos, y su empleo en medicamentos | |
SE0202465D0 (sv) | New compounds | |
EA200700367A1 (ru) | Новые производные 4-бензилиденпиперидина | |
CR10381A (es) | Uso de bifenilamidas de acido arilcarboxilico para el tratamiento de semillas | |
UY28572A1 (es) | Compuestos novedosos | |
NO20032252L (no) | Piperazinylpyrazinforbindelser som agonist eller antagonist av serotonin 5HT-2-reseptor | |
AR051767A1 (es) | Derivados de quinolina e isoquinolina 5-sustituidos un procedimiento para su preparacion y su uso como inhibidores de la inflamacion | |
ECSP088145A (es) | Derivados bicíclicos como inhibidores de la cinasa p38 | |
ECSP066541A (es) | Nuevos derivados de piridazin-3(2h)-ona | |
SE0202463D0 (sv) | Novel compounds | |
DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
AR052312A1 (es) | 2- anilinopirimidinas sustituidas como inhibidores de la quinasa del ciclo celular o del receptor de la tirosina quinasa, su preparacion y medicamentos preparados en base al compuesto | |
ECSP055567A (es) | Derivados de indolinona sustituidos en posición 6, su preparación y su uso como medicamentos | |
BRPI0508724A (pt) | derivados do fenilaminoetanol como agonistas do receptor beta2 | |
NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
BRPI0519709A2 (pt) | derivados de tetralina e indano e usos dos mesmos como antagonistas de 5-ht | |
WO2005060959A8 (en) | Pyrazole derivatives and use thereof as orexin receptor antagonists | |
RS53211B (en) | PYRIDO [2,3-d] PYRIMIDINE DERIVATIVES, THEIR PRODUCTION, THEIR USE IN THERAPY | |
RS20060072A (en) | Aminoquinoline derivatives and their use as adenosine a3 ligands | |
AR028743A1 (es) | DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA | |
UY26988A1 (es) | Nuevas indolinonas sustituidas, su preparación y su utilización como medicamentos. | |
ATE465151T1 (de) | 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |